483
Alvogen, IncAlvogen, Inc – FDA 483, Sep 11, 2020
Record Details
Alvogen, Inc. in Morristown, NJ, was cited for significant deficiencies in its adverse drug experience reporting system during an FDA inspection. The firm failed to develop written procedures for post-marketing surveillance, including social media, and submitted numerous serious and unexpected adverse drug experience reports, as well as periodic safety reports, significantly late to the FDA. These issues indicate a systemic failure in pharmacovigilance compliance.
View Company Profile
ID · 4314b30c-4c7e-4790-860d-60ad10ae2d9b
Other documents for Alvogen, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.